This week on “The Top Line,” we explore peripheral arterial disease, a serious health issue that is often overlooked and undermanaged.  

Join Editor-in-Chief of Fierce Life Sciences and Healthcare Ayla Ellison as she sits down with Kumar Madassery, M.D., Director of the Peripheral Vascular Intervention & CLI Program at Rush University Medical Center. They discuss the hidden dangers of PAD, and Dr. Madassery emphasizes the importance of early detection. He also discusses the launch of the PAD Pulse Alliance, a collaborative effort among vascular health experts aimed at raising awareness, improving early detection and reducing amputation rates. 

To learn more about the topics in this episode: 
Philips-supported campaign wants Americans to 'get a pulse on PAD' amid ignorance of the disease
Johnson & Johnson 'Save Legs. Change Lives.' campaign brings PAD amputation awareness to Black community
Bayer and J&J's Xarelto reduces ischemia risk for PAD patients after revascularization surgery

This week on “The Top Line,” we explore peripheral arterial disease, a serious health issue that is often overlooked and undermanaged.  
Join Editor-in-Chief of Fierce Life Sciences and Healthcare Ayla Ellison as she sits down with Kumar Madassery, M.D., Director of the Peripheral Vascular Intervention &amp; CLI Program at Rush University Medical Center. They discuss the hidden dangers of PAD, and Dr. Madassery emphasizes the importance of early detection. He also discusses the launch of the PAD Pulse Alliance, a collaborative effort among vascular health experts aimed at raising awareness, improving early detection and reducing amputation rates. 
To learn more about the topics in this episode: 
<ul>
<li><a href="https://www.fiercepharma.com/marketing/philips-supported-campaign-wants-americans-get-pulse-pad-amid-ignorance-disease" data-cke-saved-href="https://www.fiercepharma.com/marketing/philips-supported-campaign-wants-americans-get-pulse-pad-amid-ignorance-disease">Philips-supported campaign wants Americans to 'get a pulse on PAD' amid ignorance of the disease</a></li>
<li><a href="https://www.fiercepharma.com/marketing/johnson-johnson-save-legs-change-lives-campaign-brings-pad-amputation-awareness-black" data-cke-saved-href="https://www.fiercepharma.com/marketing/johnson-johnson-save-legs-change-lives-campaign-brings-pad-amputation-awareness-black">Johnson &amp; Johnson 'Save Legs. Change Lives.' campaign brings PAD amputation awareness to Black community</a></li>
<li><a href="https://www.fiercepharma.com/pharma/acc23-bayer-and-jjs-xarelto-reduce-ischemia-risk-pad-patients-after-revascularization" data-cke-saved-href="https://www.fiercepharma.com/pharma/acc23-bayer-and-jjs-xarelto-reduce-ischemia-risk-pad-patients-after-revascularization">Bayer and J&amp;J's Xarelto reduces ischemia risk for PAD patients after revascularization surgery</a></li>
</ul>

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning. 

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&amp;D and device development. Available every Friday morning.&nbsp;

The Top Line

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech and Fierce Pharma recount the latest industry trends and why they matter. We’ll analyze the week’s biggest business news—from mergers and marketing to drug R&D and device development. Available every Friday morning.

 

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech and Fierce Pharma recount the latest industry trends and why they matter. We&rsquo;ll analyze the week&rsquo;s biggest business news&mdash;from mergers and marketing to drug R&amp;D and device development. Available every Friday morning.
&nbsp;

Advertisement